Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of three doses of intrathecal isobaric ropivacaine for cesarean section anesthesia
IRCT20130812014333N156Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of ropivacaine in caesarean delivery (C-section) (3 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Patient satisfaction with spinal anesthesia, Blood pressure and 1 more. Started Nov 2020; status: completed.
02
Drugs
ropivacaine
03
Conditions
caesarean delivery (C-section)
Beyond the preview
Go deeper on IRCT20130812014333N156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N156.